← Back to Search

Smoking Cessation Service for Smoking Cessation

Waitlist Available
Led By Kenneth M Cummings, PhD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Be younger than 18 years old
Screening 3 weeks
Treatment Varies
Follow Upassessed 6-weeks post-discharge
Awards & highlights
No Placebo-Only Group

Study Summary

This trialaims to replicate a successful smoking cessation program in 3 different patient groups to help them quit smoking.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed 6-weeks post-discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed 6-weeks post-discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-reported smoking prevalence 6-weeks after hospitalization.
Self-reported use of FDA Approved Smoking Cessation Medication

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced Care ConditionExperimental Treatment1 Intervention
Group II: Basic Care ConditionActive Control1 Intervention
First Studied
Drug Approval Stage
How many patients have taken this drug
Enhanced Care
Completed Phase 4

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
911 Previous Clinical Trials
7,365,703 Total Patients Enrolled
Kenneth M Cummings, PhDPrincipal Investigator - Medical University of South Carolina
Medical University of South Carolina

Media Library

Basic Care Clinical Trial Eligibility Overview. Trial Name: NCT04827914 — N/A
Smoking Cessation Research Study Groups: Enhanced Care Condition, Basic Care Condition
Smoking Cessation Clinical Trial 2023: Basic Care Highlights & Side Effects. Trial Name: NCT04827914 — N/A
Basic Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04827914 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~64 spots leftby Mar 2024